Literature DB >> 7675956

Opioid blockade attenuates acquisition and expression of cocaine-induced place preference conditioning in rats.

M A Gerrits1, N Patkina, E E Zvartau, J M van Ree.   

Abstract

Endogenous opioid systems have been implicated in experimental cocaine addiction. One aspect of this involvement may be the modulation of the motivational properties of cocaine by endogenous opioids. The present study assessed the effect of opioid blockade with naloxone (NLX) on cocaine's motivational properties using the conditioned place preference procedure. Treatment with doses of NLX that did not induce place aversion (0.01-1.0 mg/kg-1, SC), dose-dependently attenuated place preference induced by cocaine (10 or 20 mg/kg-1, IP). This effect of NLX was present when administered during acquisition of cocaine-induced place preference and when administered before expression of cocaine's motivational effects. These data support the notion that the (conditioned) motivational properties of cocaine are modulated through activation of opioid systems by endogenous opioid peptides. Furthermore, it is suggested that an interaction between endogenous opioid systems and dopaminergic systems in the brain might be of importance in the motivational facilitation of experimental cocaine addiction.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7675956     DOI: 10.1007/bf02246059

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  42 in total

1.  Studies on the distinction between uptake inhibition and release of (3H)dopamine in rat brain tissue slices.

Authors:  R E Heikkila; H Orlansky; G Cohen
Journal:  Biochem Pharmacol       Date:  1975-04-15       Impact factor: 5.858

2.  Activation of hypothalamic beta-endorphin pools by reward induced by highly palatable food.

Authors:  J Dum; C Gramsch; A Herz
Journal:  Pharmacol Biochem Behav       Date:  1983-03       Impact factor: 3.533

3.  Cocaine place preference is blocked by the delta-opioid receptor antagonist, naltrindole.

Authors:  K Menkens; E J Bilsky; K D Wild; P S Portoghese; L D Reid; F Porreca
Journal:  Eur J Pharmacol       Date:  1992-08-25       Impact factor: 4.432

4.  Cocaine-induced place preference conditioning: lack of effects of neuroleptics and 6-hydroxydopamine lesions.

Authors:  C Spyraki; H C Fibiger; A G Phillips
Journal:  Brain Res       Date:  1982-12-16       Impact factor: 3.252

5.  Opiate antagonists reduce cocaine but not nicotine self-administration.

Authors:  W A Corrigall; K M Coen
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

6.  Naloxone attenuation of the effect of cocaine on rewarding brain stimulation.

Authors:  G T Bain; C Kornetsky
Journal:  Life Sci       Date:  1987-03-16       Impact factor: 5.037

7.  Blockade of endogenous opiates reduces activity in the rat.

Authors:  J M Walker; G G Berntson; T S Paulucci; T C Champney
Journal:  Pharmacol Biochem Behav       Date:  1981-01       Impact factor: 3.533

Review 8.  The role of dopamine in locomotor activity and learning.

Authors:  R J Beninger
Journal:  Brain Res       Date:  1983-10       Impact factor: 3.252

9.  Naloxone suppresses feeding and drinking but not wheel running in rats.

Authors:  M P Carey; J A Ross; M P Enns
Journal:  Pharmacol Biochem Behav       Date:  1981-04       Impact factor: 3.533

10.  Opioid mediation of cocaine-induced hyperactivity and reinforcement.

Authors:  A A Houdi; M T Bardo; G R Van Loon
Journal:  Brain Res       Date:  1989-09-11       Impact factor: 3.252

View more
  13 in total

Review 1.  Five Decades of Research on Opioid Peptides: Current Knowledge and Unanswered Questions.

Authors:  Lloyd D Fricker; Elyssa B Margolis; Ivone Gomes; Lakshmi A Devi
Journal:  Mol Pharmacol       Date:  2020-06-02       Impact factor: 4.436

Review 2.  [The endogenous opioid system and drug addiction].

Authors:  R Maldonado
Journal:  Ann Pharm Fr       Date:  2010-01-21

3.  Persistent increases in rat hypothalamic POMC gene expression following chronic withdrawal from chronic "binge" pattern escalating-dose, but not steady-dose, cocaine.

Authors:  Y Zhou; M J Kreek
Journal:  Neuroscience       Date:  2015-01-13       Impact factor: 3.590

Review 4.  Feeding, drug abuse, and the sensitization of reward by metabolic need.

Authors:  K D Carr
Journal:  Neurochem Res       Date:  1996-11       Impact factor: 3.996

5.  Cocaine place conditioning increases pro-opiomelanocortin gene expression in rat hypothalamus.

Authors:  Y Zhou; A Kruyer; A Ho; M J Kreek
Journal:  Neurosci Lett       Date:  2012-10-13       Impact factor: 3.046

Review 6.  The Nociceptin Receptor as an Emerging Molecular Target for Cocaine Addiction.

Authors:  Kabirullah Lutfy; Nurulain T Zaveri
Journal:  Prog Mol Biol Transl Sci       Date:  2015-12-23       Impact factor: 3.622

7.  The role of neuronal nitric oxide synthase in cocaine place preference and mu opioid receptor expression in the nucleus accumbens.

Authors:  Rachel-Karson Thériault; Francesco Leri; Bettina Kalisch
Journal:  Psychopharmacology (Berl)       Date:  2018-07-10       Impact factor: 4.530

8.  The rewarding action of acute cocaine is reduced in β-endorphin deficient but not in μ opioid receptor knockout mice.

Authors:  Alexander T Nguyen; Paul Marquez; Abdul Hamid; Brigitte Kieffer; Theodore C Friedman; Kabirullah Lutfy
Journal:  Eur J Pharmacol       Date:  2012-05-02       Impact factor: 4.432

9.  Neuroimmune Regulation of GABAergic Neurons Within the Ventral Tegmental Area During Withdrawal from Chronic Morphine.

Authors:  Anna M W Taylor; Annie Castonguay; Atefeh Ghogha; Pia Vayssiere; Amynah A A Pradhan; Lihua Xue; Sadaf Mehrabani; Juli Wu; Pat Levitt; Mary C Olmstead; Yves De Koninck; Christopher J Evans; Catherine M Cahill
Journal:  Neuropsychopharmacology       Date:  2015-07-23       Impact factor: 7.853

10.  Cocaine modulates the expression of opioid receptors and miR-let-7d in zebrafish embryos.

Authors:  Roger López-Bellido; Katherine Barreto-Valer; Fátima Macho Sánchez-Simón; Raquel E Rodríguez
Journal:  PLoS One       Date:  2012-11-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.